← Leaderboards
Abhishek Ashok Solanki
Edward Hines Jr Va Hospital
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2021–25$1$1$1$0$0
'21
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 1
By mechanism
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Edward Hines Jr Va Hospital
Same institution · by research overlap
Others in their field
Other Emerging Leaders on “Eligibility Determination”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$76,896,871
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Jean Macdonald · Dana-Farber Cancer Inst$26,990,229
- James Dale Berry · Brigham And Women'S Hospital$15,344,018
- Jennifer Marie Suga · Kaiser Foundation Research Institute$14,365,962
- Andrew S Huhn · Johns Hopkins University$12,205,195
Research focus
Eligibility DeterminationEnrollmentEffectivenessAdoptionAreaEconomic EvaluationAndrogen ReceptorDna SequencingCancer ControlCancer DiagnosisCancer EtiologyCessation Of LifeCharacteristicsChemotherapyClinical Trials DesignCollaborationsCombined Modality TherapyBody PartCooperative StudyCost EffectivenessCurative TreatmentsDisease OutcomeDisorder ControlFailure
Grant awards (5)
Veterans Affairs seamless phase II/III randomized trial of STAndard systemic theRapy with or without PET-directed local therapy for OligoRecurrenT prostate cancer (VA STARPORT)$0
I01 · FY2025 · VA · contact PI
Veterans Affairs seamless phase II/III randomized trial of STAndard systemic theRapy with or without PET-directed local therapy for OligoRecurrenT prostate cancer (VA STARPORT)$0
I01 · FY2024 · VA · contact PI
Veterans Affairs seamless phase II/III randomized trial of STAndard systemic theRapy with or without PET-directed local therapy for OligoRecurrenT prostate cancer (VA STARPORT)$0
I01 · FY2023 · VA · contact PI
Veterans Affairs seamless phase II/III randomized trial of STAndard systemic theRapy with or without PET-directed local therapy for OligoRecurrenT prostate cancer (VA STARPORT)$0
I01 · FY2022 · VA · contact PI
Veterans Affairs seamless phase II/III randomized trial of STAndard systemic theRapy with or without PET-directed local therapy for OligoRecurrenT prostate cancer (VA STARPORT)$0
I01 · FY2021 · VA · contact PI